Walleye Trading’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$169K Buy
12,300
+2,500
+26% +$37.7K ﹤0.01% 3215
2025
Q4
$177K Buy
9,800
+7,100
+263% +$127K ﹤0.01% 3461
2025
Q3
$50K Buy
+2,700
New +$42.4K ﹤0.01% 3961
2025
Q1
Sell
-23,600
Closed -$520K 4134
2024
Q4
$520K Sell
23,600
-3,100
-12% -$59.7K ﹤0.01% 2609
2024
Q3
$450K Buy
+26,700
New +$396K ﹤0.01% 2578

Other funds holding CLBT

Walleye Trading's CLBT Position: Q1 2026 in Review

Walleye Trading reduced its Cellebrite (CLBT) stake by 5.9% in Q1 2026, selling an estimated $5.08K and leaving 5,328 shares worth $73.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3568.

Walleye Trading first reported a position in CLBT in Q3 2024 and has held it in 3 quarters since. The position peaked at $112K in Q3 2024. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Walleye Trading held 5,328 shares of Cellebrite worth $73.4K as of Q1 2026.
  • Walleye Trading sold 337 Cellebrite shares in Q1 2026, an estimated $5.08K.
  • Cellebrite made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #3568 holding.
  • Walleye Trading first reported a position in Cellebrite in Q3 2024 and has held it in 3 quarters since.
  • Walleye Trading's Cellebrite position peaked at $112K in Q3 2024.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.